All results

1 results for impact

• Biohaven SMA

  This trial will study the efficacy and safety of taldefgrobep alfa as an adjunctive therapy for participants who are already taking a stable dose of nusinersen…

  Ages

  4 Years - 21 Years

  Sexes

  All